Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks ...

"Variations in the use of secondary CVD prevention medications over time in our contemporary cohort study suggest little to no improvement globally." HealthDay News — Use of secondary cardiovascular ...

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety ...

Broader uptake of single-pill combination (SPC) therapies—polypills—to simplify primary or secondary prevention of cardiovascular disease could have a huge impact on a global scale in the coming ...

Boston, MA - A new study demonstrates that providing a multidrug regimen of aspirin, two blood-pressure drugs, and a statin in the developing world is affordable and could have the profound effect of ...

Please provide your email address to receive an email when new articles are posted on . A polypill-based strategy may be cost-effective for primary CVD prevention in historically underserved ...

Across the world, many patients with CVD still aren’t on the recommended medications for secondary prevention, according to more than a decade’s worth of data from the 17-country Prospective Urban ...

GLP-1 drugs like Ozempic, Mounjaro, Wegovy, and Zepbound are powerful tools for treating diabetes and aiding with weight loss, but a new study suggests these medications could also help prevent ...

Heart disease calculator estimates a person’s risk of developing heart disease over the next 30 years so they can improve ...

A new study raises concerns that the PREVENT calculator may underestimate cardiovascular risk in some young adult populations.

AI-driven quantification of breast arterial calcification on imaging could ID higher-risk ...

“We’ ve known for quite some time that periodontal disease is a risk factor for cardiovascular disease,” says Yu-Ming Ni, M.D ...